Literature DB >> 18982038

Natural course of central serous chorioretinopathy without subretinal exudates in normal pregnancy.

Abdullah Al-Mujaini1, Upender Wali, Anuradha Ganesh, Carolina Montana.   

Abstract

BACKGROUND: Pregnancy is a well-known risk factor for central serous chorioretinopathy (CSCR).
METHODS: Patients were examined using slit-lamp biomicroscopy, fundus examination, fundus photography, and optical coherence tomography, making note of best-corrected visual acuity.
RESULTS: All patients had resolution of CSCR.
INTERPRETATION: We present CSCR in 3 consecutive pregnant women without subretinal exudates.

Entities:  

Mesh:

Year:  2008        PMID: 18982038     DOI: 10.3129/i08-097

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  6 in total

1.  Hypercortisolism induced atypical central serous chorioretinopathy in pregnancy.

Authors:  Tarun Choudhary; Sushil Chawla; Rahul Ray; Savio Pereira
Journal:  Med J Armed Forces India       Date:  2013-04-18

2.  Optical coherence tomography: clinical applications in medical practice.

Authors:  Abdullah Al-Mujaini; Upender K Wali; Sitara Azeem
Journal:  Oman Med J       Date:  2013-03

3.  Alternating central serous chorioretinopathy in two consecutive pregnancies.

Authors:  Abdullah Al-Mujaini; Upender Wali
Journal:  Oman J Ophthalmol       Date:  2014-05

4.  Incidence and natural course of symptomatic central serous chorioretinopathy in pregnant women in a maternity hospital in Kuwait.

Authors:  Khaled Said-Ahmed; Gamal Moustafa; Medhat Fawzy
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep

5.  Unilateral central serous chorioretinopathy in a pregnant Nigerian woman.

Authors:  Bolutife A Olusanya; Tunji S Oluleye
Journal:  Niger Med J       Date:  2015 Sep-Oct

6.  Clinical Characteristics of Pregnancy-Associated Central Serous Chorioretinopathy in the Chinese Population.

Authors:  Jia Yu; Lei Li; Chunhui Jiang; Qing Chang; Gezhi Xu
Journal:  J Ophthalmol       Date:  2021-12-16       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.